Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $28.5700 (-0.14%) ($27.7500 - $29.4100) on Fri. Oct. 5, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.96% (three month average) | RSI | 40 | Latest Price | $28.5700(-0.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.2% a day on average for past five trading days. | Weekly Trend | EDIT declines -4.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(62%) XBI(61%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -1.48% in a week (0% probabilities). VXX(-13%) VIXM(-12%) TLT(-5%) SHY(-5%) GDXJ(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.48% (StdDev 2.96%) | Hourly BBV | 0 () | Intraday Trend | -0.6% | | | |
|
1 - 5 Day Possible Target | $21.49(-24.78%) | Resistance Level | $31.33 | 5 Day Moving Average | $29.39(-2.79%) | 10 Day Moving Average | $30.6(-6.63%) | 20 Day Moving Average | $31.33(-8.81%) | To recent high | -25.6% | To recent low | 3.3% | Market Cap | $1.774b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |